Jenburkt Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on May 21, 2015, has transacted that the Board accepted the resignation of Devangi S. Shah, Independent Director and a dividend of Rs 6.30 (63%) per equity share of Rs 10 each has been recommended by the Board.
The above information is a part of company’s filings submitted to BSE.